Skip to main content
Trials
Sponsors
Conditions
Drugs
Pricing
Trials
Sponsors
Conditions
Drugs
Pricing
Loading search results
Clinical Trials for "Simon Lo"
3
trials
Share
Relevance
ID
Status
Phase
Title
Sponsor
NCT01884961
Completed
Phase 2
Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or Renal Cell Carcinoma Treated with High-dose Interleukin-2
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
ClinicalTrials.gov
NCT01884961
Completed
Phase 2
Radiotherapy As an Immunological Booster in Patients with Metastatic Melanoma or...
Istituto Romagnolo per lo...
NCT02225652
Completed
Phase 2
A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclophosphamide at Days 1, 4 Every 14 Days With Filgrastim Support Followed by Weekly Paclitaxel in Women With Primary Breast Cancer.
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
ClinicalTrials.gov
NCT02225652
Completed
Phase 2
A Phase II Study of Dose Density Regimen With Fluorouracil, Epirubicin and Cyclo...
Istituto Romagnolo per lo...
NCT02477813
Terminated
Phase 2
Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell Lung Cancer With MGMT Methylation
Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS
ClinicalTrials.gov
NCT02477813
Terminated
Phase 2
Temozolomide in Patients Affected by Relapsed Sensitive or Refractory Small Cell...
Istituto Romagnolo per lo...
Start your search
Search over 500,000 clinical trials worldwide
Search
Expert
Popular:
Cancer
Diabetes
Alzheimer
COVID-19
Heart Disease